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Pharmaceutical formulationAbstract Two accurate, precise and sensitive RP-HPLC and HPTLC-Densitometric methods have
been developed for the determination of Carbazochrome and Troxerutin in their binary mixture
without previous separation. Method (A) is RP-HPLC which depended on isocratic elution using
C18 column and mobile phase consisting of water containing (0.2% triethylamine (TEA), 1%
tetrahydrofuran (THF)):methanol (65:35, by volume) at a ﬂow rate of 1.5 mL min1 and the efﬂu-
ent was monitored at 350 nm. Good resolution was obtained with tR values of 2.069 and 5.174 min
for Carbazochrome and Troxerutin, respectively. Method (B) is HPTLC-Densitometric method,
using silica gel 60 F254 HPTLC plates and methanol:chloroform:ammonia (40:60:7, by volume)
as a developing system. The bands were scanned at 350 nm. The proposed methods have been val-
idated as per ICH guidelines and their linearity was evident in the ranges of 0.25–10 and 5–
50 lg mL1 for method (A) and 0.02–0.8 and 0.1–2 lg band1 for method (B) for Carbazochrome
and Troxerutin, respectively. The developed methods have been applied for the determination of the
above mentioned drugs in their pharmaceutical formulation where no interference from the excip-
ients has been detected. Statistical comparison of the results obtained by the developed methods and
those obtained by the reported HPLC methods showed no signiﬁcant difference between them. The
developed methods are sensitive, accurate and precise and can be easily used for quality control
analysis of the studied drugs.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Carbazochrome (CAR) is chemically designated as 3-hydroxy-
1-methyl-5,6-indolinedione semicarbazone,1 Fig. 1a. It is an
oxidation product of adrenaline and has been given as a
hemostatic.1 Troxerutin (TRO) is chemically designated as
Chemical Formula C10H12N4O3 Chemical Formula C33H42O19
   M.Wt. 236.2 M.Wt. 743
(a) (b)
Figure 1 Chemical structure of Carbazochrome (a) and Troxerutin (b).
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pyranosyl)-b-D-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxye
thoxy)-4H-1-benzopyran-4-one (tris(hydroxyethyl)rutin).2 It is
the principal component of oxerutin ﬂavonoid which is a natu-
rally occurring antioxidant that is widely distributed in plants.
Preparations containing natural or semisynthetic ﬂavonoids are
thought to improve capillary function by reducing abnormal
leakage. They have been given to relieve capillary impairment
and venous insufﬁciency of the lower limbs and for hemor-
rhoids,1 Fig. 1b. Combination of CAR and TRO medication
is indicated for capillary fragility and venous insufﬁciency.
The literature survey reveals few analytical methods for the
determination of CAR such as ﬂuorescence quenching3,4 and
chromatographic methods.5,6 The British pharmacopeia
reported IR spectrophotometric and liquid chromatographic
methods for an analysis of Troxerutin,2 also detailed literature
survey reveals that spectrophotometric,7,8 micellar chemilumi-
nescence,9 RP-HPLC10–13 and other chromatographic meth-
ods14,15 have been reported for the quantitative estimation of
Troxerutin individually in various matrices such as human
plasma, pharmaceutical dosage forms, bulk, rat urine, chicken
plasma and food supplements. RP-HPLC methods have been
reported for the determination of Troxerutin in combination
with other ﬂavonoids and other drugs.16–18 On the other hand,
there are no pharmacopeial methods available for the analysis
of Carbazochrome. Spectrophotometric methods have been
reported for the simultaneous determination of Car-
bazochrome and Troxerutin in dosage form.19
Reviewing the literature in hand, no chromatographic
methods have been published for the determination of the
studied mixture. So the aim of this work is to develop accurate,
sensitive and selective RP-HPLC and HPTLC-Densitometric
methods for simultaneous estimation of CAR and TRO in
their binary mixture and in their pharmaceutical formulation.
2. Experimental
2.1. Instruments
2.1.1. Agilent technologies, 1200 inﬁnity series LC supplied
with 1260 UV–VIS Detector with 1260 inﬁnity Agilent
technologies (25 cm  4.6 mm i.d, 5 lm particle size)Eclipse plus C18 column was used as a stationary phase
for HPLC determinations.
2.1.2. A sample applicator for TLC linomat V with 100 lL syr-
inge (Camage, Muttenz, Switzerland).
2.1.3. TLC scanner 3 densitometer (Camage, Switzerland)
controlled by WINCATS software (V 3.15, Camage).
2.1.4. HPTLC aluminum plates (20  20 cm) coated with
0.25 mm silica gel 60 F254 (Merck, Germany).
2.1.5. UV lamp with short wavelength 254 nm (VL-6.LC,
MARNE LA VALLEE cedex 1, FRANCE).
2.1.6. The following parameters were adjusted during HPTLC
scanning.
- Scanning mode: absorbance.
- Source of radiation: deuterium lamp.
- Slit dimension: 6  0.45 mm.
- Scanning speed: 20 mm s1.
2.1.7. Sonix TV ss-series ultrasonicator (USA).2.2. Materials and reagents
2.2.1. Pure standards
Carbazochrome (CAR) and Troxerutin (TRO) pure standards
were kindly supplied by MINAPHARM Egypt IND., Egypt.
Their purity was found to be 99.49% and 99.22%, respectively,
according to the manufacturer certiﬁcate.
2.2.2. Pharmaceutical formulation
Fleboton ampoules for I.M. injection (B.No. CCE0564)
manufactured by MINAPHARM Egypt IND., Egypt, labeled
to contain 1.5 mg CAR and 150 mg TRO mg per 3 mL
ampoule.
2.2.3. Chemicals and solvents
All chemicals used throughout this work were of analytical
grade and were used without further puriﬁcation;
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City, Egypt),
– methanol, chloroform, ammonia, (El-Nasr Pharmaceutical
Chemicals Co., Abu Zabaal, Cairo, Egypt).
– Tetrahydrofuran, triethylamine and methanol HPLC grade
(CHROMASOLV Sigma–Aldrich Chemie GmbH,
Germany).
2.2.4. Solutions
2.2.4.1. Stock standard solutions of CAR and TRO (0.5 and
1 mg mL1), respectively. 50 and 100 mg of CAR and TRO
respectively were accurately and separately weighed into 100-
mL volumetric ﬂasks and the volume was then completed to
the mark with methanol.
2.2.4.2. Working standard solutions of CAR and TRO
(0.1 mg mL1). They were prepared by diluting 20 mL and
10 mL from their respective stock solutions, respectively into
two separate 100-mL volumetric ﬂasks and the volume was




Chromatographic separation was performed on Eclipse
plus C18 column (25 cm  4.6 mm i.d, 5 lm particle size)
using (methanol:(0.2% triethylamine (TEA), 1% tetrahy-
drofuran (THF) solution)) (35:65, v/v) at a ﬂow rate of
1.5 mL min1 at ambient temperature and the efﬂuent
was monitored at 350 nm then peak areas and retention
times were recorded.
3.1.2. HPTLC-Densitometric method
It was performed using pre-coated silica gel HPTLC aluminum
plates (20  10 cm). The plates were pre-washed with metha-
nol and activated at 100 C for 15 min prior to samples’ appli-
cation. Samples were applied in the form of bands
(6 mm length, 12 mm spacing, and 10 mm from the bottom
edge of the plate). Linear ascending development was per-
formed in a chromatographic tank previously saturated with
methanol:chloroform:ammonia (40:60:7, by volume) for half
an hour at room temperature to a distance of about 80 mm.
The developed plates were air dried and then scanned at
350 nm.
3.2. Linearity and construction of calibration curves
3.2.1. HPLC method
Calibration graphs for CAR and TRO* were obtained by
recording and storing the peak areas of different concentra-
tions of each in the ranges of 0.25–10 lg mL1 and
5–50 lg mL1 for CAR and TRO, respectively, prepared by
suitable dilutions of their respective working solutions.
Calibration graphs were constructed by plotting relative peak
area (using 1 lg mL1 CAR and 15 lg mL1 TRO as external
standard solutions) versus the corresponding concentration
and the regression equations were then computed.3.2.2. HPTLC-Densitometric method
Accurate volumes of CAR and TRO* were separately trans-
ferred from their respective stock standard solutions (0.5 and
1 mg mL1, respectively), applied in triplicate on the pre-
washed HPTLC plates in the form of bands to obtain the con-
centration range of 0.02–0.8 and 0.1–2 lg band1 for CAR
and TRO, respectively. The procedure under chromatographic
conditions was then followed. The integrated peak area was
then recorded and a calibration curve for each component
was constructed by plotting the relative integrated peak area
(using 0.1 lg mL1 CAR and 0.6 lg mL1 TRO as external
standard solutions) versus the corresponding concentration
and the regression equations were then computed.
 Concentration of TRO is calculated as
Trihydroxyethylrutin.2
3.3. Application to pharmaceutical formulations
10 ampoules of Fleboton have been mixed and an accurate
volume equivalent to 1 and 100 mg of CAR and TRO, respec-
tively was transferred to a 100 mL-volumetric ﬂask; and the
volume was completed to the mark with methanol to obtain
a concentration of 10 and 1000 lg mL1 of CAR and TRO,
respectively.
The procedure under linearity for each method was then
followed on Fleboton ampoule and the concentrations of
CAR and TRO were determined using the computed regres-
sion equations.
4. Results and discussion
The main task of this work was to develop sensitive, selective
and accurate RP-HPLC and HPTLC-Densitometric methods
for the determination of CAR and TRO in their binary mix-
ture, with satisfactory precision for good analytical practice
(GAP).
4.1. RP-HPLC method
RP-HPLC has become the most versatile and widespread tech-
nique used by the pharmaceutical industries for quality control
and analysis of drugs. It has many applications in the ﬁeld of
pharmaceuticals including the quantitative determination of
drugs present either alone or in presence of other mixture com-
ponents.20–23 Factors affecting chromatographic separation
have been studied and optimized. Different mobile phases have
been tested to achieve the best chromatographic separation
among the studied drugs such as methanol:water (35:65 and
80:20, v/v), methanol:0.1% acetic acid solution (50:50, v/v),
acetonitrile:water (40:60 and 60:40, v/v), methanol:(0.2% tri-
ethylamine (TEA), 1% tetrahydrofuran (THF) solution)
(35:65, v/v). The use of the last system gave the best chromato-
graphic resolution with sharp symmetric peaks. Effect of scan-
ning wavelength on the sensitivity of the method was studied
by testing different scanning wavelengths (225, 254, and
350 nm) where scanning at 350 nm gave the lowest LOD and
LOQ values. After method optimization, chromatographic
separation has been achieved on Eclipse plus C18 column using
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(THF) solution)) (35:65, v/v) at a ﬂow rate of 1.5 mL min1
and the efﬂuent was monitored at 350 nm. Two peaks were
obtained at 2.069 and 5.179 min for CAR and TRO, respec-
tively, as shown in Fig. 2. Calibration graphs were constructed
by plotting the relative peak area (using 1 lg mL1 CAR and
15 lg mL1 TRO as external standard solutions) versus the
corresponding concentrations of each drug and the regression
equations were then computed and found to be:
A1 ¼ 0:8516 C1 þ 0:1547 r1 ¼ 0:9999 For CAR
A2 ¼ 0:0680 C2  0:0116 r2 ¼ 0:9999 For TRO
where A1, A2 are the relative peak areas, C1, C2 are the concen-
trations in lg mL1, and r1, r2 are the correlation coefﬁcients
of CAR and TRO, respectively. Regression equation parame-
ters are given in Table 1.
4.2. HPTLC-Densitometric method
Thin layer chromatography has become a well-established
technique for the assay of drugs either in binary or in multi-
component mixtures.24,25 The proposed method is based on
the difference in the retardation factor (Rf) between the
CAR and TRO. In order to achieve the best separation with
sharp symmetric peaks, the method has been optimized. Dif-
ferent developing systems with different ratios were tried such
as methanol:hexane (2:8, v/v), methanol:chloroform (4:6, v/v),
methanol:chloroform:acetic acid (4:6:0.1, by volume), metha
nol:chloroform:triethylamine (4:6:0.5, by volume), methanol:
chloroform:ammonia (4:6:0.7, by volume). On using the ﬁrst
system CAR and TRO had Rf values close to each other.
Replacing hexane with chloroform enhanced the separation
among the two drugs but with tailed peaks for TRO. Addition
of either acetic acid or triethylamine to the developing system
did not improve the peaks shape while using ammonia gave
sharp symmetric peaks without affecting the separation among
the two drugs. Complete separation of CAR and TRO was
achieved by using methanol:chloroform:ammonia (4:6:0.7, by
volume) as a developing system. Effect of scanning wavelength
on the sensitivity of the method was also studied by testingFigure 2 HPLC chromatogram of 10 lg mL1 ofdifferent scanning wavelengths (225, 245, 290, and 350 nm)
where scanning at 350 nm gave the optimum sensitivity with
minimum noise for the studied components. After method
optimization, compact, sharp and symmetric peaks were
obtained for CAR and TRO with signiﬁcantly different Rf val-
ues (TRO, Rf = 0.08 and CAR, Rf = 0.75), Fig. 3.
A linear relationship between the concentrations of CAR
and TRO and the relative peak areas (using 0.1 lg mL1
CAR and 0.6 lg mL1 TRO as external standard solutions)
was observed in the range of 0.02–0.8 lg band1 and 0.1–
2 lg band1 for CAR and TRO respectively, and the regres-
sion equations were computed and found to be:
A1 ¼ 8:9152 C1 þ 0:0973 r1 ¼ 0:9999 For CAR
A2 ¼ 1:2800 C2 þ 0:2141 r2 ¼ 0:9998 For TRO
where A1, A2 are the relative peak areas, C1, C2 are the concen-
trations in lg band1, and r1, r2 are the correlation coefﬁcients
of CAR and TRO, respectively. Regression equation parame-
ters are given in Table 1.
The validity of the proposed methods for the analysis of
CAR and TRO was studied by assaying Fleboton ampoule
Table 2. It was further assessed by applying standard addition
technique, which showed that there was no interference from
excipients, as in Table 2.
Statistical analysis of the results obtained by applying the
developed HPLC and HPTLC-Densitometric methods with
those obtained by the reported HPLC methods,2,5 showed no
signiﬁcant difference within conﬁdence limit of 95% regarding
both accuracy and precision, Table 3.5. Method validation
Method validation was performed according to ICH
guidelines.26
5.1. Linearity and range
Linearity of the proposed methods was evaluated and it was
evident in the range of 0.25–10 and 5–50 lg mL1 for HPLCCarbazochrome and 45 lg mL1 of Troxerutin.
Table 1 Results of assay validation parameters of the proposed HPLC and TLC-Densitometric methods for determination of
Carbazochrome and Troxerutin.
Parameters HPLC TLC-Densitometry
CAR TRO CAR TRO*
Linearity
Range 0.25–10 (lg mL1) 5–50 (lg mL1) 0.02–0.8 (lg band1) 0.1–2 (lg band1)
Slope 0.852 0.068 8.915 1.28
Intercept 0.155 0.012 0.097 0.214
Correlation coeﬃcient (r) 0.9999 0.9999 0.9999 0.9998
Accuracy (Mean) 100.82 100.27 100.67 99.45
Precision (%RSD)
Repeatabilitya 0.825 0.952 0.920 0.870
Intermediate precisionb 1.067 1.024 1.070 1.137
Robustness parameters (% RSD)
For HPLC method:
Organic solvent ratio ± 2% 0.087 0.851
Flow rate ± 0.05 mL min1 0.109 0.102
Scanning wavelength ±1 nm 0.076 0.687
For TLC-Densitometric method
Ammonia volume ±0.05 ml 0.735 0.951
Saturation time ±5 min 0.538 0.822
Scanning wavelength ±1 nm 0.189 0.547
LOD** 0.083 (lg mL1) 1.67 (lg mL1) 0.007 (lg band1) 0.033 (lg band1)
LOQ** 0.25 (lg mL1) 5 (lg mL1) 0.021 (lg band1) 0.1 (lg band1)
* Concentration of Troxerutin is calculated as Trihydroxyethylrutin.
** LOD and LOQ values were calculated using a visual non-instrumental method.26
a The intraday (n= 3), average of three different concentrations repeated three times within day.
b The interday (n= 3), average of three different concentrations repeated three times in three successive days.
Figure 3 TLC chromatogram of a mixture of (a) Troxerutin and (b) Carbazochrome using methanol: chloroform: ammonia (4:6:0.7, by
volume) as a developing system.
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Densitometric method for CAR and TRO, respectively. Lin-
earity was ensured in both HPLC and HPTLC data sets of
CAR and TRO by the use of residual data plots and normal
probability data plots as shown in Figs. 4 and 5.
Good linearity was evident from the high value of correla-
tion coefﬁcient and low value of intercept as shown in Table 1.5.2. Accuracy
Accuracy of the method was checked by applying the proposed
methods for the determination of different blind samples of
pure CAR and TRO. The concentrations were calculated from
the corresponding regression equations and the results are pre-
sented in Table 1. Accuracy of the method was further assured
Table 2 Determination of Carbazochrome and Troxerutin in pharmaceutical formulation by the proposed HPLC and TLC-
Densitometric methods and application of standard addition technique.












Fleboton B.N. ccE0564 Labeled to
contain 2.5 mg CAR and 250 mg
TRO/3 mL ampoule
CAR 94.30 ± 1.099 95.51 ± 1.127 3 99.97 0.05 99.89
4 98.26 0.1 98.12
5 100.23 0.2 100.24
6 100.45 0.3 101.03
Mean ± SD 99.73 ± 1.001 99.82 ± 1.230
TRO 105.30 ± 1.061 105.72 ± 1.191 30 100.04 0.2 101.74
35 101.94 0.3 99.40
40 101.57 0.4 101.79
45 100.38 0.5 101.45
Mean ± SD 100.98 ± 0.915 101.10 ± 1.140
Table 3 Statistical comparison of the proposed methods and the reported one for determination of Carbazochrome and Troxerutin in
their pharmaceutical formulation.
Items HPLC TLC Reported method
CAR TRO CAR TRO CAR** TRO***
Mean 94.30 105.30 95.51 105.72 99.51 104.65
SD 1.036 1.118 1.077 1.259 0.953 0.964
% RSD 1.099 1.061 1.127 1.191 0.957 0.958
N 8 8 6 6 8 8
Student’s t-test 1.233 (2.145)* 1.262 (2.145)* 0.975 (1.782)* 1.779 (2.179)*
F-value (3.972) 1.529 (3.787)* 1.278 (3.787)* 1.242 (3.972)* 1.440 (3.972)*
* Figures between parenthesis represent the corresponding tabulated values of t and F at P= 0.05.
** HPLC method for CAR determination: C18 Column, 5 lm, 250  4.6 mm column, 1 mL min1 ﬂow rate, 0.12% ammonium dihydrogen
phosphate (pH 3.0):ethanol (85:15) as a mobile phase, k= 363 nm.5
*** HPLC method for TRO determination: C18 Column, 0.5 mL min
1 ﬂow rate, acetonitrile: NaH2PO4 adjusted to pH 4.4 with dilute
phosphoric acid (20:80) as a mobile phase, k= 350 nm.2
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cal formulation where good recoveries were obtained revealing
no interference from excipients, as given in Table 2.
5.3. Precision
Repeatability: Three concentrations (4, 6 and 8 lg mL1) of
CAR and (15, 20 and 25 lg mL1) of TRO for HPLC and
(0.02, 0.1 and 0.6 lg mL1) of CAR and (0.2, 0.6 and
1 lg mL1) of TRO for HPTLC method were analyzed three
times intra-day using the proposed method. Good% RSD val-
ues were obtained conﬁrming the repeatability of the method
as given in Table 1.
Intermediate precision: The previous procedure was repeated
inter-day on three different days for the analysis of the three
chosen concentrations. Acceptable% RSD values were
obtained as given in Table 1.
5.4. Specificity
Speciﬁcity of the methods was tested by how accurately and
speciﬁcally the analytes of interest are determined in presence
of other components (e.g.co-formulated drugs, excipients,impurities, degradation products, etc). This is evident from
HPLC chromatogram and HPTLC-Densitogram in Figs. 2
and 3 proved the speciﬁcity of the proposed method.
5.5. Limit of detection and limit of quantitation
ICH recommendations26 were followed using a visual non-
instrumental method to calculate the values of LOD and
LOQ of the two studied components where LOD is the con-
centration at which the signal to noise ratio is equal to 3:1
while LOQ is the concentration at which the signal to noise
ratio is equal to 10:1. Low values of both LOD and LOQ indi-
cated the high sensitivity of the developed method, Table 1.
5.6. Robustness
Robustness of an analytical procedure is the capacity of the
method to remain unaffected with small deliberate variations
in method parameters and provides an indication of its reliabil-
ity during normal usage26 e.g.: changing ammonia volume in
the developing system±0.05 mL and changing saturation time
±5 min for HPTLC-Densitometric method and changing
organic solvents ratios ±2% and ﬂow rate ±0.05 ml min1
Figure 4 Normal probability and residual data plots for (a) Troxerutin and (b) Carbazochrome in HPLC method.
Figure 5 Normal probability and residual data plots for (a) Troxerutin and (b) Carbazochrome in HPTLC method.
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Table 4 System suitability testing parameters of HPLC and TLC methods.
Parameters Obtained value Reference values27
TLC HPLC
CAR TRO CAR TRO
Resolution (Rs) 1.23 4.78 >1.5
Selectivity factor (a) 10.7 2.503 >1
Tailing factor (T) 1.02 1 1.1 1.16 1
Capacity factor (K0) – – 1.069 4.179 1–10
Number of theoretical plates (N) – – 273.97 670.55 The higher the number,
the more eﬃcient separation
HETPa – – 9.125  10–2 3.728  10–2 The smaller, the more
eﬃcient the column
HETPa = height equivalent to theoretical plates (cm).
74 M. Mohamed Abdelrahman et al.in HPLC method and changing the scanning wavelength
±1 nm for the two methods. The low value of % RSD shows
that the methods are robust and that the deliberate small
change in the studied factors did not lead to signiﬁcant changes
in (Rf or tR) values, area or symmetry of the peaks.
5.7. System suitability
An overall system suitability testing was done to determine if
the operating system were performed properly. Parameters
including resolution (Rs) Peak asymmetry and selectivity fac-
tor (a) were calculated where good results were obtained and
peak information is given in Table 4.
Peak purity testing was done to ensure purity of the peaks
in HPLC method and the results obtained conﬁrmed the purity
of CAR and TRO peaks.
After methods validation, they have been applied for the
determination of CAR and TRO in their pharmaceutical for-
mulation and the results obtained were acceptable with small
% RSD values. The validity of the methods was further
assessed by applying the standard addition technique which
conﬁrmed the accuracy of the methods, Table 2. The results
obtained by applying the proposed methods were statistically
compared with those obtained by applying the reported HPLC
methods2,5 and the calculated F-and t-values showed no signif-
icant differences between the proposed and the reported meth-
ods as shown from the results in Table 3.
6. Conclusion
The proposed HPLC and HPTLC methods are precise, accu-
rate, reproducible, sensitive and they can be used for the rou-
tine analysis of CAR and TRO in their pharmaceutical
formulation. The advantage of the developed HPTLC-
Densitometric method is that several samples can be run simul-
taneously using a small quantity of mobile phase while HPLC
method introduces the desired reproducibility and accuracy.
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